JPMORGAN CHASE & CO - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,051,957
-7.0%
82,701
+2.9%
0.00%
Q2 2023$1,131,384
+6.9%
80,354
+17.4%
0.00%
Q1 2023$1,058,000
+87121.8%
68,445
-7.5%
0.00%
Q4 2022$1,213
-99.9%
74,012
-6.7%
0.00%
Q3 2022$1,468,000
+164.0%
79,369
+87.9%
0.00%
Q2 2022$556,000
-83.5%
42,247
-88.4%
0.00%
Q1 2022$3,369,000
+178.2%
363,481
+193.3%
0.00%
Q4 2021$1,211,000
+33.5%
123,946
+364.3%
0.00%
Q3 2021$907,000
-9.1%
26,696
-2.1%
0.00%
Q2 2021$998,000
-5.4%
27,267
+15.9%
0.00%
Q1 2021$1,055,000
+7.3%
23,535
+36.7%
0.00%
Q4 2020$983,000
+42.3%
17,217
+23.4%
0.00%
Q3 2020$691,000
-8.4%
13,947
+10.4%
0.00%
Q2 2020$754,000
+170.3%
12,630
+86.0%
0.00%
Q1 2020$279,000
-94.9%
6,789
-92.2%
0.00%
-100.0%
Q4 2019$5,427,000
+2472.0%
87,190
+1302.7%
0.00%
Q3 2019$211,000
+122.1%
6,216
+53.2%
0.00%
Q2 2019$95,000
+90.0%
4,057
+89.2%
0.00%
Q1 2019$50,000
+6.4%
2,144
-4.5%
0.00%
Q4 2018$47,000
-57.7%
2,246
-21.5%
0.00%
Q3 2018$111,000
-98.5%
2,861
-98.5%
0.00%
-100.0%
Q2 2018$7,523,000
+30.4%
191,184
-33.6%
0.00%
+100.0%
Q1 2018$5,767,000
+45.2%
287,762
+64.3%
0.00%0.0%
Q4 2017$3,971,000175,1810.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders